The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

The freeze-dried formulation will be easier to store and transport than the liquid-frozen formulation that Bavarian Nordic ...

The advisory panel to the Centers for Disease Control and Prevention had made recommendations regarding the use of separate ...

Exercised options total USD 143.6 million; Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026; COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/ ...

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

Get Bavarian Nordic A/S alerts: Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) last issued its quarterly earnings data on Wednesday, March 5th. The company reported $0.47 earnings per ...

Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...